Commonwealth Equity Services’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
+36,427
| New | +$125K | ﹤0.01% | 4025 |
|
|
2023
Q4 | – | Sell |
-12,019
| Closed | -$55K | – | 3900 |
|
|
2023
Q3 | $55K | Buy |
12,019
+1,000
| +9% | +$4.58K | ﹤0.01% | 3645 |
|
|
2023
Q2 | $71K | Sell |
11,019
-248
| -2% | -$1.6K | ﹤0.01% | 3616 |
|
|
2023
Q1 | $84 | Buy |
11,267
+722
| +7% | +$5 | ﹤0.01% | 3521 |
|
|
2022
Q4 | $106K | Sell |
10,545
-2,600
| -20% | -$26.1K | ﹤0.01% | 3408 |
|
|
2022
Q3 | $130K | Sell |
13,145
-1,913
| -13% | -$18.9K | ﹤0.01% | 3312 |
|
|
2022
Q2 | $160K | Sell |
15,058
-481
| -3% | -$5.11K | ﹤0.01% | 3271 |
|
|
2022
Q1 | $151K | Sell |
15,539
-296
| -2% | -$2.88K | ﹤0.01% | 3398 |
|
|
2021
Q4 | $226K | Sell |
15,835
-3,789
| -19% | -$54.1K | ﹤0.01% | 3194 |
|
|
2021
Q3 | $393K | Buy |
+19,624
| New | +$393K | ﹤0.01% | 2668 |
|